Skip to main content

Table 1 Unadjusted hospital resource utilization outcomes

From: 30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study

 

Non-IET

IET

 
 

N = 32,710

N = 4984

 

Antibiotics costs, $

Mean/Median

SD/IQR

Mean/Median

SD/IQR

P-value

UTI

 Mean

779

1486

1333

2655

<0.001

 Median

405

190, 844

586

226, 1332

<0.001

Sepsis

 Mean

958

2496

1736

3840

<0.001

 Median

478

226, 1007

731

310, 1782

<0.001

Pneumonia

 Mean

887

1106

918

1202

<0.001

 Median

552

269, 1067

459

183, 1148

0.098

Any

 Mean

845

1844

1381

2909

<0.001

 Median

441

206, 919

602

230, 1422

<0.001

Antibiotics costs as a fraction of total hospital costs

Mean/Median

SD/IQR

Mean/Median

SD/IQR

P-value

UTI

 Mean

4.5%

4.4%

5.0%

5.2%

<0.001

 Median

3.4%

1.9%, 5.8%

3.5%

1.8%, 6.4%

0.066

Sepsis

 Mean

4.3%

4.2%

4.3%

5.1%

0.923

 Median

3.2%

1.8%, 5.5%

3.0%

1.4%, 5.3%

<0.001

Pneumonia

 Mean

5.3%

4.4%

4.6%

4.3%

<0.001

 Median

4.1%

2.3%, 7.0%

3.2%

1.7%, 6.0%

<0.001

Any

 Mean

4.5%

4.4%

4.7%

5.0%

0.028

 Median

3.4%

1.9%, 5.8%

3.3%

1.6%, 6.0%

0.012

30-day readmission

Rate

N at risk

Rate

N at risk

P-value

UTI

20.8%

16,028

24.8%

2194

<0.001

Sepsis

20.6%

9097

26.7%

1191

<0.001

Pneumonia

23.8%

3521

25.8%

294

0.204

Any

21.1%

28,646

25.6%

4279

<0.001

  1. IET inappropriate empiric therapy, SD standard deviation, UTI urinary tract infection, IQR interquartile range